CRIS Current Research Information System

CASTELLUCCI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.753
EU - Europa 5.491
AS - Asia 2.818
AF - Africa 428
SA - Sud America 13
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.730
GB - Regno Unito 1.716
VN - Vietnam 1.098
SE - Svezia 843
CN - Cina 741
DE - Germania 720
IT - Italia 693
SG - Singapore 482
UA - Ucraina 315
IN - India 310
IE - Irlanda 271
FR - Francia 226
RU - Federazione Russa 218
TG - Togo 154
EE - Estonia 121
ZA - Sudafrica 113
CH - Svizzera 107
JO - Giordania 99
CI - Costa d'Avorio 89
BG - Bulgaria 79
FI - Finlandia 62
NG - Nigeria 46
IR - Iran 30
SC - Seychelles 22
BE - Belgio 21
CA - Canada 21
ES - Italia 18
NL - Olanda 15
JP - Giappone 13
HR - Croazia 12
PL - Polonia 9
BR - Brasile 8
CZ - Repubblica Ceca 8
GR - Grecia 7
RO - Romania 7
TR - Turchia 7
AT - Austria 6
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
PT - Portogallo 4
AU - Australia 3
BD - Bangladesh 3
BJ - Benin 3
HU - Ungheria 3
ID - Indonesia 3
KR - Corea 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DK - Danimarca 2
KZ - Kazakistan 2
MN - Mongolia 2
MX - Messico 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
HK - Hong Kong 1
IL - Israele 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
Totale 16.509
Salva come PNG Salva come JPEG
Città #
Southend 1.572
Fairfield 934
Chandler 894
Ashburn 805
Wilmington 447
Houston 445
Woodbridge 430
Seattle 406
Singapore 396
Cambridge 344
Princeton 338
Ann Arbor 279
Dublin 271
Dong Ket 234
Jacksonville 214
Lomé 154
Westminster 148
Padova 131
Nanjing 123
Bologna 113
Berlin 109
Bern 100
Amman 99
New York 92
Abidjan 89
Jinan 79
Santa Clara 75
Sofia 73
Shenyang 72
Saint Petersburg 71
Beijing 70
Turin 67
Helsinki 61
Florence 58
Boardman 55
Hebei 52
Bremen 48
Mülheim 47
Changsha 46
Abeokuta 44
Redmond 44
San Diego 44
Nanchang 41
Medford 38
Los Angeles 37
Jiaxing 36
Milan 36
Redwood City 34
Tianjin 33
Dearborn 25
Norwalk 24
Des Moines 23
Zhengzhou 22
Mahé 21
Brussels 20
Kuban 18
Falls Church 17
Haikou 17
Guangzhou 16
Taiyuan 15
Olalla 14
Hangzhou 13
Taizhou 13
Mountain View 12
Ningbo 12
Tokyo 12
Toronto 12
Zanjan 12
Kunming 11
Bühl 10
Frankfurt am Main 10
Lanzhou 10
London 10
Sacramento 10
San Venanzo 10
Barcelona 9
Chicago 9
Hyderabad 8
Leawood 8
Phoenix 8
Venezia 8
Verona 8
Amsterdam 7
Costa Mesa 7
Fuzhou 7
Monmouth Junction 7
Paris 7
Pune 7
Bratislava 6
Buffalo 6
Edinburgh 6
Istanbul 6
Rome 6
Ottawa 5
Parma 5
São Paulo 5
Washington 5
Augusta 4
Boydton 4
Fremont 4
Totale 10.979
Salva come PNG Salva come JPEG
Nome #
Combined (18)F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer. 369
18F-FDG PET early after radiotherapy in lymphoma patients. 232
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. 227
11-C-choline PET/CT imaging for localization of recurrent prostate cancer 221
11 C-CHOLINE-PET/CT FOR PREOPERATIVE N-STAGING IN HIGH RISK PROSTATE CANCER 177
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. 172
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. 169
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 167
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. 167
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel 164
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 156
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 156
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 155
11C-CHOLINE PET/TC imaging for localization of recurrent prostate cancer 150
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. 149
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. 148
11C-Choline PET/CT and Bladder Cancer: Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard 147
11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT. 146
11C-Choline PET/CT for Restaging of Bladder Cancer 141
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 139
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. 138
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 137
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 135
18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy. 134
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 134
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 133
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study. 133
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 133
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 133
18 FDG-PET nel follow.up dei pazienti con carcinoma tiroideo differenziato 132
Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer 132
11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer. 132
(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer 132
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? 132
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 130
11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer. 127
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy 127
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 126
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 124
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. 123
18f-fdg pet/ct for restaging gastric cancer after surgical resection 123
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 122
Pathological and molecular diagnosis of bilateral inguinal lymph nodes metastases from low-grade endometrial adenocarcinoma: a case report with review of the literature 122
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy. 120
null 119
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient 119
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL 118
PET-TC con 11C-colina e Spettroscopia di Risonanza Magnetica nella diagnosi e localizzazione del tumore prostatico: confronto con l'analisi seriata dello specimen chirurgico. 118
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 116
11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results 115
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. 115
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma 114
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 113
null 113
CT with 11C-Choline for identification of recurrent prostate cancer 112
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 111
Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study. 111
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. 111
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study 111
EFFETTO DELLA TERAPIA ORMONALE SULLA CAPTAZIONE DI 11-C-COLINA IN PAZIENTI CON RIPRESA DI MALATTIA DA CARCINOMA PROSTATICO 110
Erratum to: Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial. 110
POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER 109
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 108
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 107
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) E RISONANZA MAGNETICA DI SPETTROSCOPIA DEL PROTONE (1-H-MRSI) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA: STUDIO COMPARATIVO 106
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 106
Image fusione between PET and CT for radiotherapy treatment planning for head and neck cancer 105
Current Application and Future Perspectives of Prostate Specific Membrane Antigen PET Imaging in Prostate Cancer 105
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial 104
Choline PET/CT for prostate cancer: Main clinical applications. 103
Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer 103
Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer. 102
PET/TC CON 11-C-COLINA E SPETTROSCOPIA DO RISONANZA MAGNETICA NELLA DIAGNOSI E LOCALIZZAZIONE DEL TUMORE PROSTATICO: CONFRONTO CON LA ANALISI SERIATA DELLO SPICIMEN CHIRURGICO 101
Restaging Clear Cell Renal Carcinoma With 18F-FDG PET/CT. 101
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. 100
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL. 100
Role of (11)C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy 100
A Rare Case of Epididymal Metastasis After Radical Prostatectomy Detected by 68Ga-PSMA PET/CT. 100
Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis. 99
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 99
Pictorial essay: normal variants, lesions, and pitfalls in Ga-68-PSMA PET imaging of prostate cancer. 99
Imaging with (11)Carbon labelled PET tracers. 98
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. 97
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 97
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection. 96
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy? 96
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references 94
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 94
PET imaging in prostate cancer, state of the art: a review of 18F-choline and 11C-choline PET/CT applications 94
SEXTANT LOCALIZATION OF PROSTATE CANCER WITH 11C-CHOLINE PET/CT: COMPARISON WITH THREE-DIMENSIONAL PROTON MR SPECTROSCOPIC IMAGING USING STEP SECTION HISTOPATHOLOGY AS STANDARD OF REFERENCES 93
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references 93
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions. 93
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence. 93
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 92
PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer. 92
Comparative imaging evaluation before surgical resection of liver metastasis in colorectal cancer patients. First results of Italian Prometeo study 92
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA 92
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 90
New aspects of molecular imaging in prostate cancer. 90
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83. 90
Totale 12.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.277 0 0 56 229 366 375 476 534 551 254 213 223
2020/20212.223 458 129 75 82 38 116 36 181 278 87 128 615
2021/20223.581 892 89 187 293 284 139 56 193 99 180 694 475
2022/20233.755 358 541 229 474 236 291 98 200 691 128 300 209
2023/20241.126 94 163 31 68 72 220 57 262 50 56 26 27
2024/2025795 167 558 70 0 0 0 0 0 0 0 0 0
Totale 16.939